Best for
Beginner investments
Circassia Pharmaceuticals plc (CIR) is a publicly traded medical devices business based in the UK. It opened the day at 36.35p after a previous close of 34p. During the day the price has varied from a low of 36.18p to a high of 36.38p. The latest price was 36.3p (25 minute delay). Circassia Pharmaceuticals is listed on the London Stock Exchange (LSE) and employs 111 staff. All prices are listed in pence sterling.
How to buy shares in Circassia Pharmaceuticals
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: CIR in this case.
- Research Circassia Pharmaceuticals shares. The platform should provide the latest information available.
- Buy your Circassia Pharmaceuticals shares. It's that simple.
Best for
0% commission
Best for
Mobile app
Best for
Referral bonus
What's in this guide?
- Can I buy shares in Circassia Pharmaceuticals?
- Compare share dealing platforms
- Performance over time
- Is Circassia Pharmaceuticals stock a buy or sell?
- Are Circassia Pharmaceuticals shares over-valued?
- Circassia Pharmaceuticals shares summary
- Does Circassia Pharmaceuticals pay a dividend?
- How volatile are Circassia Pharmaceuticals shares?
- Other common questions
Fees for buying 500x Circassia Pharmaceuticals shares with popular platforms
Share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|
|
£0 | $10 | £0.00 £181.50 total |
Capital at risk |
|
£0 | £250 | £8.00 £189.50 total |
Capital at risk |
|
£0 | No minimum | £0.00 £181.50 total |
Capital at risk |
 |
£0 | £1 | £11.95 £193.45 total |
Capital at risk |
 |
£0 | £0.01 | £1.78 £183.28 total |
Capital at risk |
 |
£9.99 per month | No minimum | £7.99 £189.49 total |
Capital at risk |
 |
£36 per year | £20 | £9.50 £191.00 total |
Capital at risk |
Full comparison of share dealing platforms
Circassia Pharmaceuticals share price (LSE:CIR)
Use our graph to track the performance of CIR stocks over time.Circassia Pharmaceuticals price performance over time
Historical closes compared with the last close of 36.3p
| 1 month (2022-09-02) | 6.76% |
|---|---|
| 3 months (2022-07-05) | 15.24% |
| 6 months (2022-04-05) | 2.54% |
| 1 year (2021-10-04) | -19.15% |
|---|---|
| 2 years (2020-10-05) | 36.98% |
| 3 years (2019-10-04) | 128.30% |
| 5 years (2017-10-05) | -55.32% |
Is it a good time to buy Circassia Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.
Invest in Circassia Pharmaceuticals shares with IG
- No commission on US shares
- More than 13,000 shares to invest in
- Open your account in minutes
Go to site
Capital at risk
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is Circassia Pharmaceuticals under- or over-valued?
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
P/E ratio
Circassia Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, Circassia Pharmaceuticals shares trade at around 34x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Circassia Pharmaceuticals shares at a glance
Information last updated 2022-09-30.
| Open | 36.35p |
|---|---|
| High | 36.38p |
| Low | 36.18p |
| Close | 36.3p |
| Previous close | 34p |
| Change | 2.3p |
| Change % | 6.7647% |
| Volume | 19,554 |
Information last updated 2022-09-30.
| 52-week range | 29p - 49.95p |
|---|---|
| 50-day moving average | 34.592p |
| 200-day moving average | 36.5232p |
| Wall St. target price | 47p |
| PE ratio | 34 |
| Dividend yield | 0p (0%) |
| Earnings per share (TTM) | 0.01p |
Circassia Pharmaceuticals share dividends
We're not expecting Circassia Pharmaceuticals to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Share price volatility
Over the last 12 months, Circassia Pharmaceuticals's shares have ranged in value from as little as 29p up to 49.95p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Circassia Pharmaceuticals's is 1.5634. This would suggest that Circassia Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Shares similar to Circassia Pharmaceuticals
Frequently asked questions
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
More guides on Finder
-
How to buy Veru (VERU) shares in the UK
Ever wondered how to buy shares in Veru? We explain how and compare a range of providers that can give you access to many brands, including Veru.
-
How to buy C4 Therapeutics (CCCC) shares in the UK
Ever wondered how to buy shares in C4 Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including C4 Therapeutics.
-
How to buy Clever Leaves (CLVR) shares in the UK
Ever wondered how to buy shares in Clever Leaves? We explain how and compare a range of providers that can give you access to many brands, including Clever Leaves.
-
Mental health stocks: Popular mental health companies to invest in
Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.
-
Invest in pharmaceutical stocks
Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.
-
How to buy Bone Biologics (BBLG) shares in the UK
Ever wondered how to buy shares in Bone Biologics? We explain how and compare a range of providers that can give you access to many brands, including Bone Biologics.
-
How to buy Adagio Therapeutics (ADGI) shares in the UK
Ever wondered how to buy shares in Adagio Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Adagio.
-
How to buy Bolt Biotherapeutics (BOLT) shares in the UK
Ever wondered how to buy shares in Bolt Biotherapeutics? We explain how and compare a range of providers that can give you access to many brands, including Bolt Biotherapeutics.
-
How to buy Vallon Pharmaceuticals (VLON) shares in the UK
Ever wondered how to buy shares in Vallon Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Vallon Pharmaceuticals.
-
How to buy Qualigen Therapeutics (QLGN) shares in the UK
Ever wondered how to buy shares in Qualigen Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Qualigen.
Ask an Expert